Literature DB >> 5037383

The binding of digoxin by the serum proteins.

D C Evered.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5037383     DOI: 10.1016/0014-2999(72)90247-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  15 in total

1.  Some clinical implications of the protein binding of digoxin.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  The binding of gitoxin to human plasma proteins.

Authors:  N Verbeke; P Pellegrin; A Vienne; M Lesne
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

Review 3.  The quinidine-digoxin interaction in perspective.

Authors:  B Fichtl; W Doering
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

4.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 5.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

Review 6.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 7.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  Comparative studies of the protein binding of digoxin and its metabolites.

Authors:  P H Hinderling
Journal:  Agents Actions       Date:  1977-09

9.  Plasma and urinary digoxin in thyroid dysfunction.

Authors:  G M Shenfield; J Thompson; D B Horn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

10.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Authors:  D J Sumner; A J Russell
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.